Related Experiment Video
Updated: May 13, 2026

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
GRK2 negatively regulates IGF-1R signaling pathway and cyclins' expression in HepG2 cells
Zhengyu Wei1, Reginald Hurtt, Tina Gu
1Division of Transplantation, Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA. wei-zhengyu@cooperhealth.edu
Abstract:
G protein coupled receptor kinase 2 (GRK2) plays a central role in the regulation of a variety of important signaling pathways. Alternation of GRK2 protein level and activity casts profound effects on cell physiological functions and causes diseases such as heart failure, rheumatoid arthritis, and obesity. We have previously reported that overexpression of GRK2 has an inhibitory role in cancer cell growth. To further examine the role of GRK2 in cancer, in this study, we investigated the effects of reduced protein level of GRK2 on insulin-like growth factor 1 receptor (IGF-1R) signaling pathway in human hepatocellular carcinoma (HCC) HepG2 cells. We created a GRK2 knockdown cell line using a lentiviral vector mediated expression of GRK2 specific short hairpin RNA (shRNA). Under IGF-1 stimulation, HepG2 cells with reduced level of GRK2 showed elevated total IGF-1R protein expression as well as tyrosine phosphorylation of receptor. In addition, HepG2 cells with reduced level of GRK2 also demonstrated increased tyrosine phosphorylation of IRS1 at the residue 612 and increased phosphorylation of Akt, indicating a stronger activation of IGF-1R signaling pathway. However, HepG2 cells with reduced level of GRK2 did not display any growth advantage in culture as compared with the scramble control cells. We further detected that reduced level of GRK2 induced a small cell cycle arrest at G2/M phase by enhancing the expression of cyclin A, B1, and E. Our results indicate that GRK2 has contrasting roles on HepG2 cell growth by negatively regulating the IGF-1R signaling pathway and cyclins' expression.
Insights
Reduced G protein coupled receptor kinase 2 (GRK2) enhances insulin-like growth factor 1 receptor (IGF-1R) signaling in liver cancer cells. However, this GRK2 reduction did not promote cell growth but caused cell cycle arrest.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- G protein coupled receptor kinase 2 (GRK2) is crucial for regulating signaling pathways and its dysregulation impacts diseases like heart failure, arthritis, and obesity.
- Previous research indicated that GRK2 overexpression inhibits cancer cell growth.
- The specific role of GRK2 in cancer, particularly in hepatocellular carcinoma (HCC), requires further elucidation.
Purpose of the Study:
- To investigate the impact of reduced GRK2 protein levels on the insulin-like growth factor 1 receptor (IGF-1R) signaling pathway in human HCC HepG2 cells.
- To understand the consequences of GRK2 modulation on HCC cell proliferation and cell cycle progression.
Main Methods:
- Established a GRK2 knockdown HepG2 cell line using lentiviral vector-mediated short hairpin RNA (shRNA).
- Stimulated cells with insulin-like growth factor 1 (IGF-1) and analyzed IGF-1R expression, tyrosine phosphorylation, and downstream signaling components (IRS1, Akt).
- Assessed cell growth and cell cycle distribution (G2/M phase) and quantified cyclin A, B1, and E expression.
Main Results:
- Reduced GRK2 levels in HepG2 cells led to increased total IGF-1R expression and receptor tyrosine phosphorylation upon IGF-1 stimulation.
- Knockdown of GRK2 resulted in enhanced tyrosine phosphorylation of IRS1 (at residue 612) and increased Akt phosphorylation, indicating stronger IGF-1R pathway activation.
- Despite enhanced IGF-1R signaling, GRK2-reduced cells did not exhibit increased proliferation but showed a G2/M phase cell cycle arrest, associated with elevated cyclin A, B1, and E expression.
Conclusions:
- GRK2 negatively regulates the IGF-1R signaling pathway and cyclin expression in HepG2 cells.
- GRK2 plays a complex role in HCC, exhibiting contrasting effects on signaling pathways versus cell proliferation.
- Modulating GRK2 levels offers potential therapeutic insights for HCC, though its precise impact on growth requires nuanced understanding.
Related Concept Videos
Mitogens and the Cell Cycle
GPCRs Regulate Adenylyl Cylase Activity
Two...
Inhibition of Cdk Activity
Inhibition of CDK Activity
Negative Regulator Molecules
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
